![Mark A. Gallop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark A. Gallop
Founder at
Rubedo Life Sciences, Inc.
Profile
Mark A. Gallop was the founder of XenoPort, Inc. (founded in 1999) where he held the title of Senior Vice President-Research from 1999 to 2009.
He is also the founder of Rubedo Life Sciences, Inc. (founded in 2018) where he currently holds the title of Chairman, Head-Chemistry & Development.
Dr. Gallop's former job(s) include being the Director & Chief Scientific Officer at BlueLight Therapeutics, Inc. He was also the Senior Director-Combinatorial Chemistry at Affymax Research Institute from 1990 to 1999.
Additionally, he served as the Chief Scientific Officer at Nurix Therapeutics, Inc. In terms of education, Dr. Gallop holds a doctorate degree from the University of Cambridge and an undergraduate degree from Auckland University.
Mark A. Gallop active positions
| Companies | Position | Start |
|---|---|---|
Rubedo Life Sciences, Inc.
 Rubedo Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapeutics & medicines that helps to stay young | Founder | 2017-12-31 |
Former positions of Mark A. Gallop
| Companies | Position | End |
|---|---|---|
Affymax Research Institute
 Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | 1998-12-31 |
BlueLight Therapeutics, Inc.
 BlueLight Therapeutics, Inc. BiotechnologyHealth Technology Develops novel systems to analyze real-time protein function for research and clinical applications | Chief Tech/Sci/R&D Officer | - |
| NURIX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
| XENOPORT, INC. | Founder | - |
Education of Mark A. Gallop
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
16
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
BlueLight Therapeutics, Inc.
BlueLight Therapeutics, Inc. BiotechnologyHealth Technology Develops novel systems to analyze real-time protein function for research and clinical applications | Health Technology |
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Affymax Research Institute
Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
Auckland University
 Auckland University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rubedo Life Sciences, Inc.
Rubedo Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapeutics & medicines that helps to stay young | Health Technology |
- Stock Market
- Insiders
- Mark A. Gallop
